DARVIS is a health-tech company that uses AI-powered computer vision to give hospitals real-time visibility into their supply rooms. Its flagship product, Digital Shelves, uses smart PTZ cameras to continuously monitor inventory fill-levels and scan barcodes automatically, replacing manual counting with live consumption data, predictive demand planning, and automated reordering. Born in the gaming industry in 2015, the company pivoted to healthcare supply chain and now serves systems such as MD Anderson Cancer Center while operating from Cambridge, Massachusetts, with a hub in Hamburg, Germany, and a presence in Houston, Texas.
Sovato is a Santa Barbara health-tech company building the first comprehensive, system-agnostic platform for remote robotic surgery and procedures - what the industry calls telesurgery. Co-founded by surgical-robotics pioneer Yulun Wang and healthcare strategist Cynthia Perazzo, Sovato lets a skilled surgeon operate a robotic system from hundreds or thousands of miles away, aiming to extend top surgical care to patients regardless of where they live. The company has raised $41M across its rounds and helped enable the longest-distance telesurgery ever completed.
Andrew Toy is the CEO and Board Member of Clover Health (NASDAQ: CLOV), a Medicare Advantage insurer using AI to help physicians identify and treat chronic conditions earlier. A Stanford-trained computer scientist who immigrated from Hong Kong at 16, Toy built Divide (acquired by Google for $120M in 2014), led Android Enterprise at Google, then joined Clover Health in 2018 as CTO before ascending to CEO in 2023. Under his leadership, Clover achieved 51% year-over-year membership growth and its first GAAP net income in Q1 2026, powered by the Clover Assistant AI platform that diagnoses diabetes three years earlier than conventional methods.
Carta Healthcare is a San Francisco health-tech company that pairs AI with expert nurse abstractors to pull clean, registry-ready data out of messy electronic medical records. Its Atlas and Lighthouse products cut abstraction costs by more than half while hitting 98-99% inter-rater reliability, freeing clinicians and hospitals from the slow, expensive grind of manual chart review.
HealthTap is a Sunnyvale-based digital health company that connects patients with board-certified physicians 24/7 through video, phone, and text consultations. Founded in 2010, it operates a platform of 105,000 doctors across 141 specialties serving 23 million monthly members. The company pairs AI-powered symptom checking with live clinical consultations, offering affordable virtual primary and urgent care via subscription or per-visit pricing. Recent partnerships with Samsung Health, Eli Lilly's LillyDirect, and Commure signal a shift toward deep integration with major consumer and clinical platforms.
Hello Heart is a Menlo Park-based digital health company exclusively focused on cardiovascular health. Founded in 2013, it offers an AI-powered mobile app paired with a connected blood pressure monitor and smart pill box that helps members understand, track, and improve their heart health. Deployed through employers, health plans, and Medicare Advantage programs, Hello Heart has served users at 150+ Fortune 500 companies and government organizations. Independent peer-reviewed studies - including a JAMA study of 28,000+ participants - show that 84% of high-risk users reduced blood pressure over three years, with average medical cost savings exceeding $1,700 per enrolled member per year. The company has raised $148.5 million in total funding, most recently a $70 million Series D in May 2022.
Opya is a California-based early intervention therapy provider specializing in comprehensive, multidisciplinary care for children aged 18 months to 6 years diagnosed with autism. The company delivers Applied Behavior Analysis (ABA), speech therapy, occupational therapy, and feeding therapy through in-home, clinic-based, and telehealth models across Northern and Southern California. Backed by $34.7M in total funding including a $15.4M Series A in 2021 from investors including SoftBank's SB Opportunity Fund, Opya is one of only eight ABA providers in California to hold BHCOE (Behavioral Health Center of Excellence) accreditation. In 2024, the company expanded into center-based care through the acquisition of Center for Autism Spectrum Therapy (CAST) and began operating under the Spectrum Pride brand.
Brent Dover is the CEO of Carta Healthcare, an AI-powered clinical data management platform that serves hospitals and health systems nationwide using a 'Hybrid Intelligence' model combining AI with human expert abstractors. With over 20 years of healthcare technology leadership, Dover has presided over company-defining exits and growth events - including leading Medicity to a $500M acquisition by Aetna generating 16x investor returns, scaling Health Catalyst toward a NASDAQ IPO, and growing Commure to a $3.5B valuation. He joined Carta Healthcare in December 2023 and has since driven 2x revenue growth, 100% customer retention, and a $18.25M Series B1 round led by UPMC Enterprises.
Ian Christopher is the Co-Founder and Chief Engineer of Qventus, the AI-powered hospital operations platform backed by KKR and Bessemer Venture Partners. A Stanford-trained computational engineer, he co-built Qventus from a 2012 YC startup into a $400M+ company that automates how hospitals manage patient flow, surgical scheduling, and care coordination - reducing staff burnout and cutting length of stay for major health systems across the US.
Jonathan Rat is the Co-Founder and CEO of Archy, an AI-powered all-in-one dental practice management platform based in San Jose, California. A French-born software engineer with a master's in computer science, he spent a decade building payments infrastructure at Facebook, SurveyMonkey, and Uber before co-founding Archy in 2021 alongside former Uber colleagues Ben Kolin and Nimish Sheth. His motivation: watching his wife, Dr. Christine Liu, struggle daily with outdated, fragmented dental software. Archy has since raised $47 million in total funding, serves 2.5 million patients across 45 states, and processes over $100 million in annual payments.
Josh Rose is the CEO of Hawthorne Health, Inc. (formerly Hawthorne Effect), a Walnut Creek-based company building the largest community-based clinical trial site network in the U.S. A clinical research industry veteran with over 20 years of experience, Rose previously led decentralized clinical trial strategy at IQVIA and CVS Health before taking the helm at Hawthorne Health in early 2024. Under his leadership, Hawthorne has expanded to 75+ community locations, partnered with 40+ pharma sponsors, and pioneered a model that embeds certified clinical research staff inside independent pharmacies and patients' homes - bringing trials to communities that traditional research networks have long bypassed.
Dr. Michelle Longmire is the co-founder and CEO of Medable, the leading platform for agentic AI in clinical development. A Stanford-trained physician-scientist who grew up in a Los Alamos nuclear-research family, she pivoted from dermatology to founding Medable in 2015 after hitting enrollment walls in her own clinical research. Under her leadership, Medable has raised over $500 million in venture capital, deployed its platform in roughly 400 trials across 70 countries in 120 languages, and served more than one million patients globally - transforming how the world runs clinical trials.
Moawia Eldeeb is the CEO and Co-Founder of Tempo, a San Francisco-based AI-powered home fitness company that raised $316M and uses 3D sensors and computer vision to deliver real-time form correction and personalized training. Born in Alexandria, Egypt, he immigrated to the US at age 9, dropped out of school in 6th grade to work 12-hour shifts at a pizza restaurant, survived homelessness in a Harlem shelter, and put himself through Columbia University by working as a personal trainer - before building one of the most-funded fitness tech startups in history.
Dr. Mohamed Mazen Batterjee is the Co-Founder, CCO, and investor behind Aumet, an AI-first procurement operating system reshaping pharmaceutical supply chains across the Middle East. A scion of one of Saudi Arabia's oldest pharma dynasties, he parlayed a DBA from IE Business School and 15+ years running Batterjee Pharmaceuticals into co-founding a platform that now connects 12,000+ pharmacies, 1,000+ suppliers, and has processed over $1 billion in GMV. Aumet closed a $12M Series A in May 2026, bringing total funding to $21.84M.
Nikhil Buduma is the Co-Founder and CEO of Ambience Healthcare, an ambient AI platform that automates clinical documentation, coding, and revenue integrity for health systems. A two-time International Biology Olympiad gold medalist, MIT-educated computer scientist, and author of O'Reilly's 'Fundamentals of Deep Learning,' Buduma built Ambience from the ground up - first by running a medical practice, then by creating the AI platform his clinicians needed. The company has raised $343M total, reached a $1.25B valuation after a $243M Series C in 2025, and built a platform that supports 100+ medical specialties across outpatient, emergency, and inpatient settings.
Plenful is a San Francisco-based AI workflow automation company building software that takes the busywork out of pharmacy and healthcare operations. Founded in 2021 by former pharmacy operator Joy Liu, the company helps health systems, specialty pharmacies, and infusion teams automate 340B audits, rebate management, prior authorization, and patient intake - work that has long been trapped in PDFs, faxes, and spreadsheets.
Shahed Jaber is the Co-Founder of Aumet Inc, MENA's largest B2B healthcare procurement marketplace. Based in Riyadh, Saudi Arabia, he previously founded UniOrders - a B2B healthcare marketplace acquired by Aumet in 2020. With a pharmacy background from the University of Jordan, Jaber has helped grow Aumet into an AI-first procurement platform serving 12,000+ pharmacies and 32 hospitals across the MENA region, processing over $1 billion in GMV and raising $21.84M in total funding.
Charta Health is a San Francisco AI startup building a pre-bill chart review platform that reads every patient encounter, catches coding mistakes and missed revenue, and flags compliance risks before claims go out the door. Founded in 2023 by two ex-Rockset engineers who got themselves certified as medical coders, the company raised a $22M Series A in 2025 led by Bain Capital Ventures.
Vivoo is a San Francisco-based health tech company that makes at-home urine test strips analyzed via smartphone camera. Founded in 2017, the company offers a wellness platform that measures 8+ biomarkers — including hydration, vitamins, minerals, pH, ketones, and oxidative stress — and delivers personalized nutrition and lifestyle recommendations through a free mobile app. Backed by $19.4M in funding led by Tim Draper, Vivoo is sold at Target, Walmart, and Sam's Club, and has expanded to 100+ countries with a focus on making lab-grade health insights accessible to everyday consumers.
Bismarck Lepe is a serial Silicon Valley entrepreneur and the Co-Founder and CEO of MiSalud Health, a bilingual AI-powered telehealth platform serving Latino and blue-collar workers across the U.S. and Mexico. The son of Mexican immigrant farmworkers, he spent early childhood following seasonal harvests before attending Stanford and building a $1B+ career at Google, Ooyala (sold to Telstra for $400M+), and Wizeline. At MiSalud, he applies his nearshore technology playbook to a deeply personal mission: making quality healthcare accessible to the communities that shaped him.
David Foote is the Founder and CEO of zennya health, a mobile-first on-demand healthcare platform operating in the Philippines that delivers medical and wellness services to people's homes in under 30 minutes. A serial entrepreneur with 25+ years building technology companies, Foote came to the Philippines for scuba diving and stayed to build a virtual hospital infrastructure that has completed over 600,000 services. Based between San Francisco and Manila, he leads a company of 110 employees with ~$31.3M in annual revenue backed by $1.2M in seed funding.
Chris Mansi is a Cambridge and UCL-trained neurosurgeon turned AI entrepreneur, and the Co-founder and CEO of Viz.ai - the company that puts an AI brain between a CT scanner and a surgeon so that patients who are about to die of a stroke stop dying from delays. Named to TIME100 AI in 2024, Mansi built Viz.ai from a Stanford dorm-room insight into a platform covering nearly 2,000 U.S. hospitals and 230 million lives, reducing stroke diagnostic timelines by more than an hour - one patient at a time, every ten seconds.
Ellen Rudolph is the Co-Founder and CEO of WellTheory, a San Francisco-based digital health company on a mission to reverse the autoimmune epidemic. A Stanford-trained product design engineer and Functional Medicine Certified Health Coach, Ellen founded WellTheory in 2022 after her own years-long battle with debilitating autoimmune symptoms drove her to create the empathetic, evidence-based care she wished she'd had. WellTheory has since raised $33.4M in total funding—including a $14M Series A led by General Catalyst in October 2025—and achieved 10x year-over-year member growth and 5x revenue growth, serving 50 million Americans navigating autoimmune conditions.
Fawad Butt is the co-founder and CEO of Penguin AI, a Palo Alto-based healthcare AI platform company that raised $29.7M in Series A funding in September 2025. A former Chief Data Officer at Kaiser Permanente, UnitedHealthcare, and Optum, Butt spent years on the buyer side spending hundreds of millions on generic tech before deciding to build the solution healthcare actually needed. Penguin AI targets the $1 trillion annual administrative burden in US healthcare with purpose-built agentic AI, small language models, and digital workers that compress prior authorization reviews from 30 minutes to under two, positioning itself as 'the Epic of the healthcare back office.'
Mike Novotny is the founder and CEO of Medrio, a San Francisco-based eClinical SaaS company he started in his apartment in 2005. Over 15 years he bootstrapped Medrio into a nine-figure company that has helped customers win regulatory approvals for more than 100 treatments. After a sabbatical researching organizational development, he returned as CEO in 2025, betting that AI will reshape clinical trial data management. Before Medrio, he was CEO of Telosa, President of Ninaza, a UN research associate, and managed the fraud database at Visa. He holds degrees from Stanford, PUC Chile, and Columbia.
Sharam Fouladgar-Mercer is the Co-Founder and CEO of Signos, the company behind the first FDA-cleared over-the-counter glucose monitoring system for weight management. A Princeton computer science graduate and Harvard MBA, he played NCAA Division I ice hockey before building a career spanning VC at Sierra and Shasta Ventures, co-founding PR tech company AirPR (later Onclusive), and ultimately creating Signos in 2018 after his own lifelong struggle with weight and the death of his diabetic grandmother inspired him to ask: why wait until someone is sick to give them metabolic data?
David Kopp is the CEO of Sleep Doctor, a direct-to-consumer sleep health company operating SleepDoctor.com, SleepFoundation.org, and SleepApnea.org. A Harvard-educated literature major who pivoted from journalism into internet media, Kopp spent a decade as CEO of Healthline Media - growing it from 1 million to 70 million monthly US visitors and engineering a 5X private equity return before stepping down in 2020. He now brings that playbook to Sleep Doctor, where he's betting the same formula of trusted health content plus e-commerce can crack a market where 50+ million Americans suffer from sleep disorders but access to quality care remains stubbornly difficult.
Max Blacker is an Investment Analyst at LDV Capital, a venture firm focused on visual technology and computer vision. A former professional soccer player who played for Crewe United FC in Belfast's Northern Irish 4th Division, he turned a leave of absence from Brandeis University into a founding moment - launching SETGK, a goalkeeper glove company that became one of the fastest-growing brands in the space. He holds a BA in Business from Brandeis and an MS in Finance from Johns Hopkins Carey School of Business, where he also kicked field goals for the football team and was a Global Finalist in the 2024 Venture Capital Investment Competition. At LDV Capital, he focuses on the intersection of visual technology with sports, health, and nutrition.
Joel Cutler is the co-founder and Managing Director of General Catalyst, one of the most influential venture capital firms in the world. Since co-founding the firm in 2000 with David Fialkow - a partnership forged at summer camp at age 8 - Cutler has backed transformative companies including Airbnb, Warby Parker, Venmo, Lemonade, and KAYAK, which he literally conceived and assembled from scratch. A law school graduate who never practiced law, a self-described non-visionary who keeps a 'Wall of Shame' of deals he missed, and a travel obsessive who attended Phocuswright for 20+ consecutive years, Cutler operates with a contrarian philosophy: he only wants 'exciting, different, and risky' bets, believes great teams beat great ideas every time, and insists that if you don't fail, you're a bad investor.
Esther Dyson is a Swiss-American technology investor, author, and former journalist whose career has spanned five decades and multiple reinventions - from fact-checker at Forbes to the founding chair of ICANN, from running the most influential tech conference of the 1990s to training as a backup cosmonaut in Star City, Russia. The daughter of physicist Freeman Dyson, she built EDventure Holdings and its newsletter Release 1.0 into required reading for Silicon Valley's elite before pivoting to angel investing in health tech, AI, and aerospace. Now working on her book 'Term Limits: Time and Scale in the Age of AI' (MIT Press, 2027), she remains one of tech's most original and independent thinkers, guided by her personal motto: 'Always make new mistakes.'